Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)

China flag China · Delayed Price · Currency is CNY
28.99
+1.02 (3.65%)
Apr 29, 2026, 1:24 PM CST
86.07%
Market Cap 11.35B
Revenue (ttm) 704.16M
Net Income (ttm) 22.26M
Shares Out 405.71M
EPS (ttm) 0.05
PE Ratio 509.78
Forward PE 155.39
Dividend n/a
Ex-Dividend Date n/a
Volume 5,010,210
Average Volume 7,922,818
Open 27.69
Previous Close 27.97
Day's Range 27.47 - 29.17
52-Week Range 14.93 - 34.68
Beta 0.39
RSI 44.63
Earnings Date Mar 31, 2026

About SHA:688319

Chengdu Olymvax Biopharmaceuticals Inc. engages in the research and development, production, and sales of vaccines for human use in China. The company offers absorbed tetanus vaccine, group a and group c products; and haemophilus influenzae type b products. The company was founded in 2009 and is based in Chengdu, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 451
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688319
Full Company Profile

Financial Performance

In 2025, SHA:688319's revenue was 704.16 million, an increase of 19.58% compared to the previous year's 588.86 million. Earnings were 22.26 million, an increase of 7.24%.

Financial Statements

News

There is no news available yet.